Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway. [electronic resource]
Producer: 20181003Description: 111-121 p. digitalISSN:- 1879-0631
- Animals
- Cytokines -- metabolism
- Diabetes Mellitus, Experimental -- complications
- Diabetic Angiopathies -- etiology
- Endothelium, Vascular -- drug effects
- Male
- NF-kappa B -- antagonists & inhibitors
- Rats
- Rats, Sprague-Dawley
- Saponins -- pharmacology
- Signal Transduction
- Toll-Like Receptor 4 -- antagonists & inhibitors
- Triterpenes -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.